Posts in Japan pharma

A conceptual illustration of an hourglass with a human brain at the top, releasing a cascade of binary code (1s and 0s) and data symbols. At the bottom red bulb, two robotic hands are analyzing and sorting this data into categories marked by red checkmarks and black cross-marks. A factory and cherry blossoms are in the background.
by Stefan Sandström
June 24, 2026

Beyond the $2.1B Hype: Why Biology Remains the Kingmaker

The biopharma world is still processing the seismic news of Isomorphic Labs’ $2.1 billion Series B […]
0
read more
Wide editorial illustration showing Takeda’s logo above a red launch ramp, with global connections, Tokyo skyline elements, and strategic icons for clear priorities, accelerated execution, innovation, sustainable growth, and worldwide impact.
by Stefan Sandström
May 13, 2026

Takeda’s JPY 200 Billion Pivot: Welcome to Takeda’s New Launch Machine

The JPY 200 billion savings target currently dominating Takeda’s internal dialogue isn’t just a number on […]
1
read more
Illustration of Japan’s evolving drug pricing trends with a balance scale metaphor.
by Stefan Sandström
March 12, 2025

Rethinking Japan: Is the Era of Relentless Drug Price Cuts Ending?

Is Japan’s Drug Pricing Squeeze Finally Loosening? Japan has long been a high-pressure pricing environment for […]
0
read more